Cargando…
NICE guidance for moderate RA—a step in the right direction
Autor principal: | The Lancet Rheumatology |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767464/ https://www.ncbi.nlm.nih.gov/pubmed/36567872 http://dx.doi.org/10.1016/S2665-9913(21)00226-5 |
Ejemplares similares
-
COVID-19: a time to reflect
por: The Lancet Rheumatology
Publicado: (2020) -
Too long to wait: the impact of COVID-19 on elective surgery
por: The Lancet Rheumatology
Publicado: (2021) -
Communication combats hesitancy
por: The Lancet Rheumatology
Publicado: (2021) -
COVID-19: is the rush to boost backed by science?
por: The Lancet Rheumatology
Publicado: (2021) -
COVID-19 vaccine data provide reassurance
por: The Lancet Rheumatology
Publicado: (2021)